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cardiomyopathy, PH, heart failure with pre‑
served ejection fraction (HFpEF), and valvular 
heart disease.5 From a simple method such as 
wall motion analysis by 2‑dimensional echo‑
cardiography, M ‑Mode, pulsatile and contin‑
uous color, and tissue Doppler, we have now 
moved on to the next ‑generation laboratory, 
employing a variety of up ‑to ‑date technolo‑
gies such us deformation imaging, lung ultra‑
sound, and 3‑dimensional echocardiography.4 
The parameters measured during the stress test 
combined with exercise capacity, blood pres‑
sure, and heart response will provide a com‑
prehensive, low‑cost, noninvasive assessment 
of cardiovascular pathologies.
Stress echocardiography for noncoronary 
indications focuses on the following: 1) assess‑
ment of the true functional class of the patient 
when a discrepancy is observed between the re‑
ported lack of symptoms and the objective as‑
sessment of pathology as severe; 2) establishing 
a correlation between exertional symptoms and 
Introduction Stress echocardiography (SE) 
has an established essential role in evidence‑
‑based guidelines as a diagnostic tool in daily 
cardiology practice. It is not only a valid and 
useful method for the diagnostic and prognos‑
tic stratification of patients with coronary ar‑
tery disease (CAD)1 but it also shows an emerg‑
ing value in the assessment of cardiac function 
in other cardiovascular conditions.2‑ 4 Unfor‑
tunately, apart from CAD, the application is 
still somewhat marginal in the routine cardi‑
ology practice. Stress echocardiography pro‑
vides the opportunity to identify the function 
of the microvasculature and heart valves, de‑
tect possible pulmonary hypertension (PH), 
lung congestion, and also evaluate the sys‑
tolic and diastolic reaction and mechanics of 
the left or right ventricle (LV/RV) in response 
to load. For this reason, SE permits recogni‑
tion of many causes of cardiac symptoms in 
addition to ischemic heart disease, including 
hypertrophic cardiomyopathy (HCM), dilated 
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Stress echocardiography is a safe, low ‑cost, widely available, radiation ‑free versatile imaging modality that 
is becoming increasingly recognized as a valuable tool in the assessment of coronary heart disease. In recent 
years, there has also been an increasing use of stress echocardiography in the assessment of nonischemic 
cardiac disease given its unique ability for simultaneous assessment of both functional performance and 
exercise ‑related noninvasive hemodynamic changes, which can help guide treatment and inform about 
the prognosis of the patients. Today, in the echocardiography laboratory, we can not only detect wall motion 
abnormalities resulting from coronary artery stenosis, but also detect alterations to the coronary microvessels, 
left ventricular systolic and diastolic parameters, heart valves, pulmonary circulation, alveolar ‑capillary 
barrier, and right ventricle. The role of stress echo has been well established in several pathologies, such 
as aortic stenosis and hypertrophic cardiomyopathy; however, other indications, namely the results of 
diastolic stress testing and pulmonary hypertension, need additional data and research. This paper presents 
the current evidence for the role of stress testing in mitral regurgitation, aortic stenosis, hypertrophic 
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Nonsevere mitral regurgitation with symptoms
In pa tients with complaints in whom there is 
suspicion of severe MR but it is not evident on 
resting echocardiogram, SE demonstrating pro‑
gression of MR helps to correlate the pathology 
with the patient’s symptoms. However, as stress 
tests may worsen any MR, concomitant increase 
in PASP supports MR as the cause of symptoms. 
The dataset in symptomatic patients should in‑
clude color flow Doppler (to allow offline quanti‑
fication of severity by proximal isovelocity sur‑
face area method and vena contracta of the re‑
gurgitant jet), MR continuous wave Doppler to 
quantify the severity by the proximal isoveloci‑
ty surface area method, tricuspid regurgitation 
continuous wave Doppler to estimate the PASP, 
and LV views to assess global and regional sys‑
tolic function (FigurE 1).1 The therapeutic impli‑
cations of exercise‑induced severe MR are not 
clearly defined. The European Society of Car‑
diology (ESC) guidelines do not specifically ad‑
dress this issue even though they recommend 
SE for evaluation of exercise‑induced changes 
in MR severity.9
Secondary mitral regurgitation In secondary 
MR, lower thresholds have been proposed be‑
cause, compared with the primary MR, the ad‑
verse outcomes are associated with a smaller 
calculated effective regurgitant orifice area.9
In patients with secondary MR, exercise SE 
is recommended in the following settings: 1) pres‑
ence of exertional symptoms which cannot be ex‑
plained with LV systolic dysfunction or MR se‑
verity at rest; 2) recurrent and unexplained acute 
pulmonary edema; 3) nonsevere MR at rest in pa‑
tients scheduled for coronary artery bypass surgery 
(CABG) to identify those who may benefit from 
combined revascularization and mitral valve repair.
The management of chronic secondary MR is 
less clear. As secondary MR is just one part of 
the disease in LV dysfunction, restoration of mitral 
valve competence is not by itself curative. There‑
fore, the indication for surgery in secondary MR 
and the choice of intervention (repair versus re‑
placement) remain debatable. Surgery is indicat‑
ed in patients with severe secondary MR at rest 
and LVEF of more than 30% undergoing CABG 
(ESC / European Association for Cardio ‑Thoracic 
Surgery guidelines class I, level of evidence C).9 
At the same time, the management of moderate 
MR, or dynamic MR at the time of CABG, and mod‑
erate or severe MR in patients not requiring revas‑
cularization remains highly controversial. Current 
European guidelines note that echocardiograph‑
ic quantification of MR during exercise may pro‑
vide prognostic information of dynamic charac‑
teristics of MR; however, there is no suggestion 
about the impact of the stress test on treatment.9
Aortic stenosis According to the latest ESC 
guidelines, both the diagnostic workup and 
the hemodynamic changes derived from echo‑
cardiography and signs unmasked by stress test; 
3) assessment of LV contractile reserve in pa‑
tients who are considered surgical candidates.6
The purpose of this paper is to review the pres‑
ent status of SE in conditions other than CAD, 
focusing on mitral regurgitation (MR), aortic 
stenosis (AS), HCM, HFpEF, and PH.
Mitral regurgitation MR results from sev‑
eral pathological conditions. Primary MR is 
defined as regurgitation resulting from organ‑
ic valvular pathology such as prolapse, rheu‑
matic lesions, chordal rupture, collagen vascu‑
lar disease, or damage from endocarditis. Sec‑
ondary MR results from ischemic or myopath‑
ic alternations (ischemic, dilated, or HCM) to 
the LV leading to incomplete closure of the mi‑
tral leaflets.7 Risk stratification using SE, partic‑
ularly in patients without symptoms, becomes 
important not only in the exact diagnosis and 
characterization of the etiology of MR but also 
in guiding therapy.
Severe primary mitral regurgitation without symp‑
toms In patients with primary MR, SE may pro‑
voke symptoms during the exercise. During daily 
activities, the patients might limit their physical 
activity and therefore not develop symptoms. Di‑
agnosis and follow ‑up in these patients are very 
important because conservatively managed as‑
ymptomatic severe MR and an effective regurgi‑
tant orifice area of more than 40 mm2 have an ex‑
cess risk of death and cardiac events.8
To assess MR changes during SE, a  semi‑
‑supine bicycle is the best choice. Since MR is 
severe at rest, there is no need to assess MR 
severity during stress. For this reason, imag‑
ing should first focus on acquiring LV views for 
the assessment of regional and global LV systol‑
ic function and to calculate global longitudinal 
strain. Continuous‑wave Doppler measurement 
of tricuspid regurgitation jet for estimation of 
pulmonary artery systolic pressure (PASP) is es‑
sential. The development of symptoms at low 
workload and severe MR with ejection fraction 
(EF) of more than 30% is class I, level of confi‑
dence B, indication for surgery.9 Besides the de‑
velopment of symptoms, there are several other 
indices that indicate poor prognosis in patients 
with severe MR. These include exercise‑induced 
increase in PASP of 60 mm Hg or more,10,11 ab‑
sence of LV contractile reserve,1,12 and limited 
RV contractile recruitment (defined as peak‑ex‑
ertion tricuspid annular plane systolic excur‑
sion <19 mm).13 Ejection fraction is traditionally 
used as the measure to assess contractile reserve, 
with a rise in left ventricular ejection fraction 
(LVEF) on exertion of less than 4% indicating 
the absence of contractile reserve. An absolute 
increase in global longitudinal strain of less than 
2% indicates lack of contractile reserve.1
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flow reserve is the aim. In the case of asymp‑
tomatic patients with severe AS, exercise SE is 
recommended.
The recommended types of SE along with 
the minimum acquired dataset and most im‑
portant findings depending on indication are 
listed in TAbLE 1.
Asymptomatic severe aortic stenosis In patients 
with severe AS in whom symptoms have not 
developed yet, exercise SE is recommended to 
unmask symptoms or pathologic blood pres‑
sure responses.1 It also has remarkable prog‑
nostic value: an elevation of 18 to 20 mm Hg 
or higher in the mean aortic pressure gradi‑
ent, or a decrease / no change in LVEF and in‑
duced PH (≥60 mm Hg) are markers of poor 
prognosis.15 ‑18
the therapeutic approach to AS is based on echo‑
cardiographic assessment.9 Surgical repair or 
transcatheter aortic valve implantation is recom‑
mended in patients with severe AS with other‑
wise not explained symptoms and / or LV systolic 
dysfunction (class I).9 The criteria for severe AS 
are: peak transvalvular velocity of 4 m/s or high‑
er or the mean transvalvular pressure gradient 
of 40 mm Hg or higher without a high flow state 
present and aortic valve area (AVA) of less than 
1 cm2.14 However, these criteria are fulfilled only 
in the case of the high ‑gradient AS. In several 
other clinical settings, when the valve morphol‑
ogy is suspicious of AS, the guidelines recom‑
mend SE to assess the severity of AS and to guide 
the therapeutic decision through risk stratifi‑
cation. Low ‑dose dobutamine SE is the chosen 
method if the assessment of the contractile or 
D
GLS, –22.2%
 Figure 1 Stress echocardiography of a 56-year -old woman with mitral valve prolapse and uncertain symptoms. The mitral regurgitation severity did not increase during 
the exercise and preserved contractile reserve was observed (elevation in the left ventricular ejection fraction [LVEF] and global longitudinal strain [GLS]). The estimated 
pulmonary artery systolic pressure (PASP) did not increase significantly. During a 4‑year follow ‑up, cardiac disease (along with mitral regurgitation and LVEF) did not progress.
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is less than 1  cm2, indexed AVA is less than 
0.6 cm2/m2, and the mean gradient is less than 
40 mm Hg at rest. It is considered the most chal‑
lenging group. The diagnostic workup recom‑
mended by the guidelines is the same as de‑
scribed with the classical LFLG type. According 
to the guidelines, in these patients, AVR is recom‑
mended if symptoms are present and severe AS 
has been confirmed (class IIa, level of evidence C).9
Hypertrophic cardiomyopathy Sufficient 
data have now been collected showing that exer‑
cise testing is not only safe but also that it is a key 
element in the comprehensive evaluation of 
patients with HCM.19 Exercise ‑related symp‑
toms in patients with HCM are due to a number 
of factors including increased LV outflow tract 
(LVOT) gradients, MR, diastolic dysfunction, 
and myocardial ischemia in the absence of epi‑
cardial CAD. The recent ESC guidelines assign 
a IB class of recommendation to perform exer‑
cise SE in symptomatic patients without a rest‑
ing LVOT obstruction (if bedside maneuvers fail 
to induce LVOT gradient ≥50 mm Hg) to detect 
exercise ‑induced LVOT obstruction and MR.19 
LVOT obstruction developing rapidly at lower 
levels of exercise is associated with greater im‑
pairment in functional capacity compared with 
Classic low ‑flow, low‑gradient aortic stenosis 
In patients with low ‑flow, low‑gradient aortic ste‑
nosis (LFLG AS) with reduced systolic function 
(stroke volume [SV] index <35 ml/m², AVA <1 cm², 
aortic velocity <4 m/s, MG <40 mm Hg, and 
LVEF <50%) low ‑dose dobutamine SE is recom‑
mended to assess the stress ‑induced symptoms, 
blood pressure change, change in pressure gradi‑
ents or AVA, and to determine the flow (defined as 
SV increase ≥20%) and contractile reserve. Typi‑
cally, in true severe AS, a marked increase in gradi‑
ents can be observed with no or minimal increase 
in AVA. AVR is indicated in symptomatic patients 
with true severe AS (class I, level of evidence B) 
or in case of symptomatic patients, whose gradi‑
ents did not elevate but the AVA remained small‑
er than 1 cm2 and the presence of flow / contrac‑
tile reserve has been proved (class I, level of evi‑
dence C).9 If the symptomatic patient’s AVA and 
gradient measurements have not changed during 
the SE and there is no contractile / flow reserve 
(which suggests an operative mortality of 30%–
50%, the therapeutic decision making is possible 
only after CT calcium scoring of the aortic valve.9
Paradoxical low ‑flow, low‑gradient aortic stenosis 
Paradoxical LFLG AS is present if LVEF is 50% 
or higher, SV index is 35 ml/m2 or less, AVA 
Table 1  The recommended types of stress echocardiography with the minimum acquired dataset and most important findings depending on 
indication. Adapted from Lancellotti et al.1
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Abbreviations: AS, aortic stenosis; AV, aortic valve; AVA, aortic valve area; AVR, aortic valve repair; CW, continuous ‑wave; GLS, global longitudinal strain; LV, left ventricular; 
LVOT,­left­ventricular­outflow­tract;­MR,­mitral­regurgitation;­PASP,­pulmonary­artery­systolic­pressure;­PPM,­patient­‑prosthesis­mismatch;­PW,­pulsed­‑wave;­TR,­tricuspid­
regurgitation
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velocity which then persists throughout systo‑
le (“bell ‑shaped”).21 Key findings of worse prog‑
nosis are: limited exercise capacity, an abnormal 
blood pressure response (hypotensive or blunt‑
ed response), significant ST ‑depression, induc‑
ible wall motion abnormalities, blunted coro‑
nary flow reserve, LVOT obstruction (more than 
50 mm Hg), and blunted systolic function. In‑
terestingly, some patients can show a paradox‑
ical decrease in LVOT obstruction during exer‑
cise, which is associated with a more favorable 
outcome and suggests alternative reasons for 
symptoms (FigurE 2b). Another paradoxical phe‑
nomenon can be also observed when the LVOT 
gradient starts to elevate after the stress test 
(FigurE 2C). The potential explanation is that in the 
recovery phase the preload and afterload rapid‑
ly drop down, and therefore the left ventricular 
volumes and dimensions decrease as well, which 
contributes to the LVOT obstruction (FigurE 2C).
Heart failure with preserved ejection frac-
tion SE has been extensively validated in pa‑
tients with heart failure with reduced ejection 
fraction.22‑24 Left ventricular contractile reserve 
is associated with a greater chance of response 
to the cardiac resynchronization therapy.23,25 
Shortness of breath, exertional fatigue, or poor 
exercise capacity has been increasingly recog‑
nized as the consequence of diastolic dysfunc‑
tion and considered to be the main cause in ap‑
proximately 40% of patients presenting with 
heart failure. HFpEF is a complex pathophysi‑
ological entity. Echocardiographic parameters 
provide a key tool for the diagnosis of the dis‑
ease, as indicated in the new ESC guidelines.26 
HFpEF is defined as the presence of heart failure 
symptoms and signs with normal or preserved 
left ventricular EF and normal or small LV vol‑
umes. Structural heart disease can be also ob‑
served, which most often means LV hypertro‑
phy or left atrial enlargement. Furthermore, evi‑
dence of diastolic dysfunction (abnormal E/e’ ra‑
tio [averaged ≥13] and abnormal e’ <9 cm/s) can 
support the diagnosis too.26 A strong correlation 
between E/e’ and physical activity has been dem‑
onstrated in HFpEF.27 E/e’ has been compared to 
an invasive hemodynamic measurement during 
exercise and the correlation was in an acceptable 
range.28 However, it is not infrequent for patients 
with HFpEF to fall within a “grey zone” of E/e’ 
value.26 In the case of SE, multiparametric ap‑
proach is considered (FigurE 3). During the stress 
test, PASP should be measured. Stroke volume 
and its change during exercise should also be 
assessed.29 With diastolic heart failure during 
stress, lung ultrasound may show B ‑lines or ul‑
trasound lung comets, which is a simple, direct, 
semiquantitative sign of extravascular lung wa‑
ter accumulation.30 The absence of increased 
cardiac output during exercise, average E/e’ ra‑
tio higher than 14, the septal e’ velocity smaller 
later onset of the gradient.20 Posteriorly direct‑
ed MR is a secondary consequence of systolic an‑
terior motion. The MR jet may overlap and con‑
taminate the LV outflow jet, potentially resulting 
in an erroneous overestimation of the subaor‑
tic gradient. Doppler systolic flow shape typical 
of LV outflow gradients characteristically dem‑
onstrates a gradual increase in velocity in early 
systole with mid ‑systolic acceleration and peak‑
ing (“dagger ‑shaped”) (FigurE 2A). Whereas the MR 
signal begins suddenly at the onset of systo‑
le and rapidly establishes markedly increased 
A
Peak gradient, 12 mm Hg
Rest
Peak gradient, 107 mm Hg
Peak stress
B Rest
Peak gradient, 179 mm Hg Peak gradient, 78 mm Hg
Peak stress
C Peak stress 
Peak gradient, 104 mm Hg Peak gradient, 138 mm Hg
After 2 min of recovery
Figure 2 Continuous -wave Doppler echocardiography of 3 patients. A – in the first patient, 
obstruction of the left ventricular outflow tract (LVOT) was developed during exercise 
(12–107 mm Hg). B – in the second patient, the high peak gradient with the dagger shaped 
envelope measured in the LVOT decreased during exercise (179–78 mm Hg). C – in the third 
patient, the high LVOT gradient reached its peak not at peak stress, but 2 minutes after 
terminating the exercise (104–138 mm Hg).







 Figure 3 Assessment of right ventricular pressure, left ventricular filling, left ventricular output, and extravascular lung water in patients with unexplained 
dyspnea and suspected heart failure with preserved ejection fraction
 Abbreviations: E/e’, ratio of early mitral inflow velocity to mitral annular early diastolic velocity; others, see FigurE 1








 Figure 4 Assessment of right ventricular pressure, noninvasively measured dynamic pulmonary vascular resistance (PVR), tricuspid annular plane systolic 
excursion (TAPSE), and left ventricular filling pressure in patients at risk of pulmonary hypertension
 Abbreviations: CO, cardiac output; others, see FigurES 1 and 3
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than 7 cm/s at baseline, peak tricuspid regurgi‑
tation velocity higher than 2.8 m/s with exer‑
cise usually indicate an abnormal stress test.1,31
Pulmonary hypertension Patients with certain 
types of pathologies are at significantly increased 
risk for pulmonary arterial hypertension (PAH). 
Annual screening with rest echocardiography has 
been proposed for these patients (systemic sclerosis, 
heritable form of PAH, first degree relatives of a pa‑
tient with heritable PAH, portal hypertension, HIV 
infection, sickle cell disease). The stimulating con‑
cept of exercise ‑induced PH (as a possible transi‑
tional phase anticipating resting PH) has been de‑
veloped in several pathologies including system‑
ic sclerosis. Several studies report significant per‑
centages of patients with normal pulmonary pres‑
sure at rest but abnormal hemodynamic response 
during stress.32‑34 This high percentage of exercise‑
‑induced increase in pressure at SE clearly overesti‑
mates the subset of patients who will develop PAH.
Stress echocardiography should be performed 
on a semirecumbent cycle ergometer with an in‑
cremental workload of 25 every 2 minutes up 
to  the symptom ‑limited maximal tolerated 
workload.35 The minimum acquired dataset in‑
cludes tricuspid regurgitant velocity and RV size 
and systolic function (tricuspid annular plane 
systolic excursion), lateral annular tissue Dop‑
pler, and RV free wall systolic strain, cardiac out‑
put, and depending on the referral indication, 
LV size and systolic, diastolic function (FigurE 4). 
Doppler recordings should be obtained with‑
in 1 to 2 minutes of test completion.1 Postexer‑
cise imaging is less reliable since PASP is known 
to return to baseline very quickly.
During the examination, focusing on PASP 
with exercise is not enough. Studies have sug‑
gested that an assessment of pulmonary vas‑
cular resistance is more sensitive.36 A steeper 
slope of the dynamic pulmonary vascular re‑
sistance curve suggests a cohort at increased 
risk for the development of PAH.36 The inabili‑
ty to augment PASP with exercise, likely an in‑
direct surrogate of impaired contractile reserve, 
is associated with worse outcome.37
conclusion Stress echocardiography is an ef‑
fective, noninvasive, cost ‑efficient, radiation‑
‑free, and easily reproducible method, which 
plays an important role in the diagnostic and 
prognostic evaluation of nonischemic heart dis‑
eases. While the benefit of SE in the evalua‑
tion of several heart diseases (for example HCM 
and CAD) is well established, its role in other 
diseases, such as mitral valve pathologies, HF‑
pEF, or PH, has been for now more limited to 
the assessment of the prognosis. In these pa‑
thologies, the importance of SE in therapeu‑
tic decision making is not undoubtedly proven. 
Further multicenter studies are needed to clar‑
ify the uncertainty.
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